We are live on ! Find out more
GC

Grimes & Company Portfolio holdings

AUM $4.62B
1-Year Est. Return 29.71%
This Fund
S&P 500
This Quarter Est. Return
+9.6%
1 Year Est. Return
+29.71%
3 Year Est. Return
+66.17%
5 Year Est. Return
+73.59%
10 Year Est. Return
+287.63%
AUM
$3.02B
AUM Growth
+$434M
Cap. Flow
+$190M
Cap. Flow %
6.3%
Top 10 Hldgs %
45.02%
Holding
338
New
35
Increased
173
Reduced
106
Closed
7
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPEM icon
101
State Street SPDR Portfolio Emerging Markets ETF
SPEM
$17.2B
$4.66M 0.15%
131,570
+178
+0.1% +$6.05K
VOO icon
102
Vanguard S&P 500 ETF
VOO
$979B
$4.24M 0.14%
9,700
-100
-1% -$40.9K
JHMM icon
103
John Hancock Multifactor Mid Cap ETF
JHMM
$5.92B
$4.18M 0.14%
79,307
-2,154
-3% -$104K
IPAY icon
104
Amplify Mobile Payments ETF
IPAY
$170M
$3.74M 0.12%
+80,690
New +$3.29M
VBK icon
105
Vanguard Morningstar Small-Cap Growth ETF
VBK
$23.1B
$3.67M 0.12%
15,195
-351
-2% -$76.2K
MCD icon
106
McDonald's
MCD
$192B
$3.6M 0.12%
12,134
-21
-0.2% -$5.72K
TXN icon
107
Texas Instruments
TXN
$252B
$3.46M 0.11%
20,324
+254
+1% +$39.4K
SPSM icon
108
State Street SPDR Portfolio S&P 600 Small Cap ETF
SPSM
$17.1B
$3.3M 0.11%
78,189
-7,714
-9% -$291K
MA icon
109
Mastercard
MA
$506B
$3.24M 0.11%
7,601
+295
+4% +$119K
IEO icon
110
iShares US Oil & Gas Exploration & Production ETF
IEO
$580M
$3.16M 0.1%
33,880
+155
+0.5% +$14.7K
TXT icon
111
Textron
TXT
$14.7B
$2.89M 0.1%
70,694
-558
-0.8% -$43.3K
PFE icon
112
Pfizer
PFE
$143B
$2.88M 0.1%
100,071
+14,488
+17% +$438K
LLY icon
113
Eli Lilly
LLY
$1.02T
$2.84M 0.09%
4,879
+952
+24% +$556K
NVDA icon
114
NVIDIA
NVDA
$4.86T
$2.73M 0.09%
55,100
+2,270
+4% +$105K
SUSA icon
115
iShares ESG Optimized MSCI USA ETF
SUSA
$4.01B
$2.71M 0.09%
26,953
+718
+3% +$67K
VWO icon
116
Vanguard FTSE Emerging Markets ETF
VWO
$121B
$2.62M 0.09%
63,644
-7,280
-10% -$289K
IDXX icon
117
Idexx Laboratories
IDXX
$44.1B
$2.61M 0.09%
4,699
+273
+6% +$128K
EEM icon
118
iShares MSCI Emerging Markets ETF
EEM
$28.8B
$2.6M 0.09%
64,734
-672
-1% -$25.9K
ITW icon
119
Illinois Tool Works
ITW
$82.6B
$2.52M 0.08%
9,617
+334
+4% +$80K
SYK icon
120
Stryker
SYK
$125B
$2.51M 0.08%
8,366
+21
+0.3% +$5.89K
EMR icon
121
Emerson Electric
EMR
$83.9B
$2.5M 0.08%
25,637
-3,443
-12% -$315K
IWN icon
122
iShares Russell 2000 Value ETF
IWN
$14.3B
$2.48M 0.08%
15,949
+122
+0.8% +$16.9K
IBM icon
123
IBM
IBM
$211B
$2.47M 0.08%
15,078
+325
+2% +$49.1K
LRGF icon
124
iShares US Equity Factor ETF
LRGF
$3.58B
$2.46M 0.08%
50,866
-741
-1% -$33.4K
DIA icon
125
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$45.8B
$2.44M 0.08%
6,465
+1,194
+23% +$417K

Similar funds

Grimes & Company's Q4 2023 Portfolio in Review

As of Q4 2023, Grimes & Company held 338 positions worth $3.02B, up 17% from $2.59B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Grimes & Company deployed $190M of net new capital in Q4 2023, opening 35 new positions and adding to 173 existing holdings. Its largest new stake was iShares 0-5 Year High Yield Corporate Bond ETF: 3,933,072 shares worth $166M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Vanguard Short-Term Corporate Bond ETF, an estimated $163M trimmed.

  • Grimes & Company's largest Q4 2023 buy was iShares 0-5 Year High Yield Corporate Bond ETF: 3,933,072 shares worth $166M.
  • Grimes & Company added most to iShares Core MSCI Emerging Markets ETF in Q4 2023, an estimated $83M increase.
  • Grimes & Company's biggest Q4 2023 reduction was Vanguard Short-Term Corporate Bond ETF, cutting an estimated $163M.
  • Grimes & Company fully exited State Street Financial Select Sector SPDR ETF in Q4 2023, selling an estimated $11.8M.
  • Grimes & Company's ten largest holdings make up 45% of its $3.02B portfolio in Q4 2023.
  • Grimes & Company opened 35 new positions and closed 7 in Q4 2023.
  • Grimes & Company's portfolio value rose 17% quarter-over-quarter to $3.02B.

Based on Grimes & Company's 13F filing for Q4 2023, filed 24 Jan 2024.